Starting with anti-rheumatic drugs, Shri U.N. Mehta discovered largely untapped territory in marketing medicines to specific segments. This was ‘niche marketing’ in its earliest form, a radical departure from the usual practice of those times and Shri Mehta’s great contribution to the Indian pharmaceutical industry.

As with any pioneering effort, it was not easy going at first. But, dogged determination and faith saw the creation of one landmark after another; the launch of a tranquilizer, Trinicalm Plus, for the niche central nervous system (CNS) segment in 1970; the setting up of Torrent’s first manufacturing facility in the early 80s; diversification into power with the acquisition of two of the country’s oldest utilities, The Ahmedabad Electricity Company Ltd. and The Surat Electricity Company Ltd., in the 90s; and the commissioning of a bulk drug manufacturing plant in the same decade.

Over the years, Torrent has remained focused on pharma and power, two crucial sectors without which modern life is unimaginable. Today, it is deservedly known as ‘India’s leading producer of life supporting drugs with a significant presence in the power sector’.